IN VITRO RESPIRABLE PERFORMANCE OF AMIKACIN DRY POWDER VERSUS AMIKACIN NEBULIZATION

被引：0
|
作者：
Balducci, Anna Giulia [1 ,2 ]
Borella, Fabio [1 ]
Bettini, Ruggero [3 ]
Colombo, Paolo [3 ]
Buttini, Francesca [3 ]
机构：
[1] PlumeStars Srl, Via Lago Scuro 11, Parma, Italy
[2] Univ Parma, Interdept Ctr, Biopharmanet TEC, Parco Area Sci 27-A, I-43100 Parma, Italy
[3] Univ Parma, Dept Pharm, Parco Area Sci 27-A, I-43100 Parma, Italy
来源：
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY | 2016年 / 29卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
73
引用
收藏
页码：A23 / A23
页数：1
相关论文
共 50 条
  • [1] Liposomal amikacin dry powder inhaler: Effect of fines on in vitro performance
    Shah, SP
    Misra, A
    [J]. AAPS PHARMSCITECH, 2004, 5 (04)
  • [2] Liposomal amikacin dry powder inhaler: Effect of fines on in vitro performance
    Shrenik P. Shah
    Ambikanandan Misra
    [J]. AAPS PharmSciTech, 5
  • [3] FORMULATING AMIKACIN FOR DRY POWDER INHALATION
    Sibum, I.
    Grasmeijer, F.
    Hagedoorn, P.
    Frijlink, H. W.
    [J]. JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2019, 32 (02) : A7 - A7
  • [4] RESPIRABLE AMIKACIN DRY POWDERS FOR INHALATION BY QUALITY BY DESIGN PROCEDURE
    Belotti, S.
    Rossi, A.
    Colombo, P.
    Bettini, R.
    Rekkas, D.
    Politis, S.
    Colombo, G.
    Balducci, A. G.
    Buttini, F.
    [J]. JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2015, 28 (04) : A9 - A9
  • [5] CEFTRIAXONE AND AMIKACIN VERSUS CEFTAZIDIME AND AMIKACIN IN FEBRILE GRANULOCYTOPENIA
    SCHMID, L
    JESCHKO, M
    WILDERSMITH, C
    SCHAFROTH, U
    THURLIMANN, B
    PEDRAZZINI, A
    SENN, H
    [J]. CHEMOTHERAPY, 1991, 37 (05) : 346 - 352
  • [6] AMIKACIN PLUS CEFTAZIDIME VERSUS AMIKACIN PLUS PIPERACILLIN VERSUS AMIKACIN PLUS AZTREONAM IN INFECTIONS IN NEOPLASTIC PATIENTS WITH GRANULOCYTOPENIA
    CASALI, A
    AMEGLIO, F
    GIONFRA, T
    TONACHELLA, R
    PAOLETTI, G
    CURCIO, CG
    [J]. CHEMIOTERAPIA, 1987, 6 (06): : 440 - 444
  • [7] MOXALACTAM AMIKACIN VERSUS TICARCILLIN AMIKACIN IN GRANULOCYTOPENIC PATIENTS - REPLY
    DEJONGH, CA
    WADE, JC
    SCHIMPFF, SC
    [J]. AMERICAN JOURNAL OF MEDICINE, 1983, 74 (06): : 1092 - 1092
  • [8] PIPERACILLIN PLUS AMIKACIN VERSUS CEFOTAXIME PLUS AMIKACIN IN NEUTROPENIC AND FEVERISH PATIENTS WITH MALIGNANT HEMOPATHIES
    PAVONE, V
    SPECCHIA, G
    GUARINI, A
    CONIGLIO, M
    IACULLI, L
    GIRARDI, F
    COLUCCI, A
    LISO, V
    [J]. CHEMIOTERAPIA, 1988, 7 (05): : 330 - 335
  • [9] PIPERACILLIN TAZOBACTAM AMIKACIN VERSUS PIPERACILLIN AMIKACIN TEICOPLANIN IN THE EMPIRICAL-TREATMENT OF NEUTROPENIC PATIENTS
    MICOZZI, A
    NUCCI, M
    VENDITTI, M
    GENTILE, G
    GIRMENIA, C
    MELONI, G
    MARTINO, P
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (01) : 1 - 8
  • [10] AMIKACIN ONCE DAILY PLUS METRONIDAZOLE VERSUS AMIKACIN TWICE DAILY PLUS METRONIDAZOLE IN COLORECTAL SURGERY
    DACOSTA, PM
    KAUFMAN, L
    [J]. HEPATO-GASTROENTEROLOGY, 1992, 39 (04) : 350 - 354
12345